Fifty 1 Labs, Inc.
Consumer Automotive Finance Inc. operates as a retailer in the used vehicle market of the United States. It focuses primarily on the buy here/pay here segment of the independent used vehicle sales and finance market. The company sells approximately 2000 and newer model-year used vehicles and provides related financing through sale type leases. As of December 31, 2010, it had two retail locations … Read more
Market Cap & Net Worth: Fifty 1 Labs, Inc. (FITY)
Fifty 1 Labs, Inc. (PINK:FITY) has a market capitalization of $8.70 ($8.70) as of March 19, 2026. Listed on the PINK stock exchange, this USA-based company holds position #50783 globally and #15548 in its home market, demonstrating a -35.71% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Fifty 1 Labs, Inc.'s stock price $0.00 by its total outstanding shares 9671 (9.67K).
Fifty 1 Labs, Inc. Market Cap History: 2025 to 2025
Fifty 1 Labs, Inc.'s market capitalization history from 2025 to 2025. Data shows growth from $8.70 to $8.70 (0.00% CAGR).
Fifty 1 Labs, Inc. Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Fifty 1 Labs, Inc.'s valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
No P/S ratio data available
Latest Price to Earnings (P/E) Ratio
No P/E ratio data available
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| No financial ratio data available | |||||
Competitor Companies of FITY by Market Capitalization
Companies near Fifty 1 Labs, Inc. in the global market cap rankings as of March 19, 2026.
Key companies related to Fifty 1 Labs, Inc. by market ranking:
- Zoetis Inc (NYSE:ZTS): Ranked #410 globally with a market cap of $53.52 Billion USD.
- Haleon plc (NYSE:HLN): Ranked #434 globally with a market cap of $49.87 Billion USD.
- Takeda Pharmaceutical Co. Ltd. (PINK:TKPHF): Ranked #457 globally with a market cap of $47.47 Billion USD.
- Jiangsu Hengrui Medicine Co Ltd (SHG:600276): Ranked #721 globally with a market cap of $28.19 Billion USD ( CN¥206.84 Billion CNY).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #410 | Zoetis Inc | NYSE:ZTS | $53.52 Billion | $121.68 |
| #434 | Haleon plc | NYSE:HLN | $49.87 Billion | $10.60 |
| #457 | Takeda Pharmaceutical Co. Ltd. | PINK:TKPHF | $47.47 Billion | $30.07 |
| #721 | Jiangsu Hengrui Medicine Co Ltd | SHG:600276 | $28.19 Billion | CN¥55.11 |
Fifty 1 Labs, Inc. Historical Marketcap From 2025 to 2025
Between 2025 and today, Fifty 1 Labs, Inc.'s market cap moved from $8.70 to $ 8.70, with a yearly change of 0.00%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2025 | $8.70 | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of Fifty 1 Labs, Inc. was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $8.70 USD |
| MoneyControl | $8.70 USD |
| MarketWatch | $8.70 USD |
| marketcap.company | $8.70 USD |
| Reuters | $8.70 USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.